However, the expression of BAX-interacting factor-1 (BIF-1)—a protein that supports Bax-mediated apoptosis—is significantly decreased in CRC tissues [116], resulting in impaired Bax activity, defective apoptosis, and reduced therapy response [116]. Here, BAX is linked to colorectal carcinoma.